OrbitalRx

Winston-Salem, NC · Founded 2017 · Privately Held (backing)

Developer of drug shortage management software designed to assist the hospital pharmacy team in improving medication shortages. OrbitalRx is based in Winston-Salem, NC and was founded in 2017. It was valued at $25.2 million at its seed round in Oct 2025, the last priced event on record. It has raised $7.4 million across 6 recorded rounds; the latest was a $1.2 million seed round in Aug 2025.

PMV mark · valuation
$25.2M
Oct 2026
Priced at
its seed round
Oct 2025
Total raised
$7.4M
Last round
Seed Round
Aug 2025
What is OrbitalRx worth?
$25.2MPrivateMarketView mark · Oct 2026

Valued at $25.2M at its seed round, Oct 2025. Nothing has traded since.

Free account
More of OrbitalRx with a free account
  • ·Watch OrbitalRx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

OrbitalRx funding history

6 rounds
DateRoundRaisedPost-money
Aug 2025Seed Round$1.2M▮
Jan 2025Seed Round$959K▮
May 2024Seed Round$856K▮
May 2023Seed Round$1.4M▮
Feb 2020Debt$733K▮
Oct 2018Seed Round$2.1M▮
Unlock post-money valuations

Membership and data by Private Market View

OrbitalRx valuation

OrbitalRx was valued at $25.2 million at its seed round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has OrbitalRx raised?

OrbitalRx has raised $7.4 million across 6 recorded rounds since 2018. The largest was a $958,932 seed round in Jan 2025; the most recent was a $1.2 million seed round in Aug 2025.

OrbitalRx has filed 8 Form Ds with the SEC since 2018, most recently in Mar 2025 ($958,932 sold to 18 investors).

How OrbitalRx's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For OrbitalRx, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about OrbitalRx

What is OrbitalRx worth?
OrbitalRx is valued at $25.2M as of Oct 2026. Valued at $25.2M at its seed round, Oct 2025. Nothing has traded since.
How much has OrbitalRx raised?
OrbitalRx has raised $7.4M in total funding across 6 recorded rounds.
When did OrbitalRx last raise?
OrbitalRx last raised in Aug 2025 (Seed Round), raising $1.2M.